Three experiments were conducted to investigate the effects of beta-glucan supplementation on pig performance and immune function. In Exp. 1, 100 weaned pigs (8.65 +/- 0.42 kg of BW and 28 +/- 2 d of age) were used in a 35-d experiment to determine the effects of graded levels of beta-glucan. Pigs were randomly allotted to 1 of 5 treatments containing beta-glucan supplemented at 0, 25, 50, 100, or 200 ppm. Each treatment was replicated using 5 pens containing 4 pigs per pen. The ADG of pigs between d 14 to 28 and d 0 to 28 responded to dietary beta-glucan in a quadratic fashion (P < 0.05), whereas beta-glucan had no effect on ADFI and G:F in any period. In Exp. 2, 80 crossbred pigs (8.23 +/- 0.56 kg of BW and 28 +/- 2 d of age) were used in a 35-d experiment. Pigs were allotted to 1 of 2 dietary treatments (0 or 50 ppm of beta-glucan in the diet) using 10 pens with 4 pigs per pen. Pigs treated with beta-glucan had greater ADG in the 14- to 28-d (P = 0.05) and 0-to 28-d (P = 0.035) periods. The ADFI of pigs receiving beta-glucan was increased (P < 0.05) in the periods from 0 to 14, 0 to 28, and 28 to 35 d. The lymphocyte proliferation index in response to phytohemagglutinin (P = 0.051) and concanavalin A (P = 0.052) tended to decrease on d 14 in pigs supplemented with beta-glucan compared with pigs without supplementation. In Exp. 3, 24 barrows (8.89 +/- 0.20 kg of BW and 28 d of age) were used to investigate the immunological and somatotropic responses of pigs challenged with lipopolysaccharide (LPS). Experimental treatments were arranged in a 2 x 2 factorial, with the main effects of LPS challenge (saline vs. LPS) and dietary addition of beta-glucan (0 vs. 50 ppm). Pigs were raised individually in metabolic cages. Pigs were fed 0 or 50 ppm of beta-glucan for 28 d and then challenged with LPS (25 microg/kg of BW) or saline. After LPS injection, blood was obtained at 0, 1.5, 3, 4.5, 6, and 7.5 h to determine cytokine production and the somatotropic response. Dietary beta-glucan increased plasma interleukin-6 at 1.5, 3, and 4.5 h and tumor necrosis factor-alpha at 3 and 4.5 h and increased plasma interleukin-10 from 3 to 7.5 h after LPS challenge. The beta-glucan treatments had no effect on growth hormone. In conclusion, beta-glucan can selectively influence performance and partially offer benefits on somatotropic axis and immune function in weaned piglets challenged with LPS.
Among binary compounds, there is a high potential for discovery of novel members (polymorphic phases or compounds) of the nitrides of transition metals group due to a pronounced dependence of the oxidation state of the metals (M) on pressure. The power of high pressure–high temperature (HP‐HT) route for synthesis of binary nitrides has already been demonstrated by the discovery of cubic nitrides of the group 4 and 14 elements, of crystalline polymorphs of P3N5, and by reports on formation of four noble metal nitrides. It is anticipated that such HP products exhibit, in addition to enhanced elastic and mechanical behavior, other functional properties making them interesting for industrial applications. Here, HP–HT synthesis research is extended to nitrides of group 5 elements, resulting in the discovery of a novel hard tantalum nitride, exhibiting U2S3 structure: η‐Ta2N3 (Pbnm, a = 8.1911(17) Å, b = 8.1830(17) Å, c = 2.9823(3) Å). The stoichiometry is supported by two independent means, verifying that η‐Ta2N3 is the first thermodynamically stable transition metal nitride with a N:M ratio exceeding 4:3. Due to its high hardness and peculiar texture (needle‐like and granular crystallites), η‐Ta2N3 may find practical applications as a hard fracture resistant material.
A multinary nitride, Eu-doped CaAlSiN 3 , which had previously been synthesized at 1600-1800 °C as a red-emiting phosphor material, was obtained at 500-800 °C via the reaction of a CaAlSi alloy with a low concentration of Eu (composition Ca 0.992 Eu 0.008 AlSi) in ammonia in the present study. In supercritical ammonia (100 MPa), CaAlSiN 3 was formed at temperatures g 500 °C both with and without the addition of sodium amide. The addition of sodium amide significantly facilitated the synthesis and prevented the presence of unreacted silicon, which could be due to the formation of sodium ammonometallates as intermediates in the presence of sodium amide. CaAlSiN 3 was synthesized even in an atmospheric ammonia flow, but the crystallinity of the product was rather low. Evidence suggested that CaAlSiN 3 was insoluble in the pressurized sodium amide-ammonia medium under the present conditions, and the prolonged reaction of the alloy in ammonia at the CaAlSiN 3 -forming temperatures (500-800 °C) did not result in an effective improvement of the crystallization. In contrast, well-crystallized samples with plate-and bar-like nanocrystals were synthesized by first converting the alloy at 300-400 °C into sodium ammonometallates and subsequently decomposing the ammonometallates up to 800 °C into CaAlSiN 3 . The products showed a red emission centered at 630-644 nm at a blue excitation of 460 nm. Instead of using sodium amide, the use of sodium azide, which was converted into sodium amide during heating, led to a product of plate-like crystals with significantly reduced oxide (oxide-free in the XRD spectrum) but did not result in an improved light emission. The size and lattice strain were calculated by refining against the XRD patterns, and the elemental composition was obtained via energy dispersive X-ray analysis on single nanocrystals with TEM observations. The synthetic conditionssstructure and compositionslight emission relationships were discussed. The deficiency in calcium was the determining factor for the decreased light emission.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.